Nigel R. A. Beeley

1.0k total citations
25 papers, 648 citations indexed

About

Nigel R. A. Beeley is a scholar working on Molecular Biology, Organic Chemistry and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Nigel R. A. Beeley has authored 25 papers receiving a total of 648 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Organic Chemistry and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Nigel R. A. Beeley's work include Monoclonal and Polyclonal Antibodies Research (6 papers), Chemical Synthesis and Analysis (5 papers) and Click Chemistry and Applications (4 papers). Nigel R. A. Beeley is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (6 papers), Chemical Synthesis and Analysis (5 papers) and Click Chemistry and Applications (4 papers). Nigel R. A. Beeley collaborates with scholars based in United Kingdom, United States and Japan. Nigel R. A. Beeley's co-authors include Kenneth Millar, Andrew T. Millican, Byron A. Boyce, David Parker, Karl J. Jankowski, Michael A. W. Eaton, J. P. Cox, Carleton R. Sage, Andrew S. Craig and I. M. HELPS and has published in prestigious journals such as Diabetes, Biochemical Journal and Tetrahedron.

In The Last Decade

Nigel R. A. Beeley

24 papers receiving 600 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nigel R. A. Beeley United Kingdom 14 238 224 223 144 76 25 648
Edward R. Bacon United States 18 453 1.9× 321 1.4× 77 0.3× 83 0.6× 75 1.0× 57 988
Thomas W. Ku United States 19 315 1.3× 469 2.1× 275 1.2× 197 1.4× 36 0.5× 33 1.1k
Edward L. Engelhardt United States 15 342 1.4× 260 1.2× 140 0.6× 49 0.3× 37 0.5× 44 786
Monica J. Kochanny United States 12 191 0.8× 378 1.7× 66 0.3× 111 0.8× 187 2.5× 18 803
Wasyl Halczenko United States 13 352 1.5× 448 2.0× 93 0.4× 72 0.5× 34 0.4× 49 1.0k
Carsten Hocke Germany 15 257 1.1× 298 1.3× 280 1.3× 86 0.6× 28 0.4× 25 751
Kondareddiar Ramalingam United States 16 231 1.0× 329 1.5× 89 0.4× 64 0.4× 65 0.9× 60 653
Bernd Riedl Germany 20 482 2.0× 684 3.1× 162 0.7× 148 1.0× 89 1.2× 42 1.2k
Goreti Ribeiro Morais United Kingdom 15 285 1.2× 248 1.1× 139 0.6× 138 1.0× 46 0.6× 51 613
T. Arunachalam United States 14 123 0.5× 340 1.5× 184 0.8× 197 1.4× 30 0.4× 43 737

Countries citing papers authored by Nigel R. A. Beeley

Since Specialization
Citations

This map shows the geographic impact of Nigel R. A. Beeley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nigel R. A. Beeley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nigel R. A. Beeley more than expected).

Fields of papers citing papers by Nigel R. A. Beeley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nigel R. A. Beeley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nigel R. A. Beeley. The network helps show where Nigel R. A. Beeley may publish in the future.

Co-authorship network of co-authors of Nigel R. A. Beeley

This figure shows the co-authorship network connecting the top 25 collaborators of Nigel R. A. Beeley. A scholar is included among the top collaborators of Nigel R. A. Beeley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nigel R. A. Beeley. Nigel R. A. Beeley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Beeley, Nigel R. A., et al.. (2023). 6-LB: GPR119 Agonist PRM A Increases Glucagon Response to Hypoglycemia in Rats. Diabetes. 72(Supplement_1).
2.
Funakoshi, Takeo, Shigeyuki Chaki, Graeme Semple, et al.. (2005). Discovery of 4-(dimethylamino)quinazolines as potent and selective antagonists for the melanin-concentrating hormone receptor 1. Bioorganic & Medicinal Chemistry Letters. 15(10). 2565–2569. 23 indexed citations
3.
Smith, Brian M., Jeffrey M. Smith, James H. Tsai, et al.. (2005). Discovery and SAR of new benzazepines as potent and selective 5-HT2C receptor agonists for the treatment of obesity. Bioorganic & Medicinal Chemistry Letters. 15(5). 1467–1470. 70 indexed citations
4.
Beeley, Nigel R. A. & Carleton R. Sage. (2003). GPCRs: an update on structural approaches to drug discovery. 2(1). 19–25. 31 indexed citations
5.
Beeley, Nigel R. A.. (2001). Medicinal Chemistry – An Introduction. Drug Discovery Today. 6(7). 346–346. 38 indexed citations
6.
Beeley, Nigel R. A.. (2000). Can peptides be mimicked?. Drug Discovery Today. 5(8). 354–363. 24 indexed citations
7.
Beeley, Nigel R. A. & K S Prickett. (1996). Section Review Oncologic, Endocrine & Metabolic: The amylin, CGRP and calcitonin family of peptides. Expert Opinion on Therapeutic Patents. 6(6). 555–567. 7 indexed citations
8.
Chander, Surinder K., Pari Antoniw, Nigel R. A. Beeley, et al.. (1995). An in Vivo Model for Screening Peptidomimetic Inhibitors of Gelatinase A. Journal of Pharmaceutical Sciences. 84(4). 404–409. 10 indexed citations
9.
Adair, John R., Nigel R. A. Beeley, Martyn C. Davies, et al.. (1994). Conformational differences in two mutant hinge IgG4 antibodies observed by scanning tunneling microscopy. Journal of Vacuum Science & Technology B Microelectronics and Nanometer Structures Processing Measurement and Phenomena. 12(3). 1517–1520. 6 indexed citations
10.
Beeley, Nigel R. A.. (1994). Peptidomimetics and small-molecule drug design: Towards improved bioavailability and in vivo stability. Trends in biotechnology. 12(6). 213–216. 12 indexed citations
11.
Porter, John, Nigel R. A. Beeley, Byron A. Boyce, et al.. (1994). Potent and selective inhibitors of gelatinase-a 1. hydroxamic acid derivatives. Bioorganic & Medicinal Chemistry Letters. 4(23). 2741–2746. 33 indexed citations
12.
Morphy, J. Richard, Nigel R. A. Beeley, Byron A. Boyce, et al.. (1994). Potent and selective inhibitors of gelatinase-A 2. carboxylic and phosphonic acid derivatives. Bioorganic & Medicinal Chemistry Letters. 4(23). 2747–2752. 31 indexed citations
13.
Beeley, Nigel R. A., et al.. (1994). A general synthesis of N-substituted isothiazol-3(2H)-ones. Journal of the Chemical Society Perkin Transactions 1. 2245–2245. 12 indexed citations
15.
Beeley, Nigel R. A., et al.. (1992). Overview: Macrocyclic Chelators as Anticancer Agents in Radioimmunotherapy. 2(10). 1539–1553. 1 indexed citations
16.
Harrison, A., David Parker, Karl J. Jankowski, et al.. (1991). The in vivo release of 90Y from cyclic and acyclic ligand-antibody conjugates. International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology. 18(5). 469–476. 62 indexed citations
17.
Alexander, Rikki, et al.. (1991). Cephalosporin Nitrogen Mustard Carbamate prodrugs for “ADEPT”.. Tetrahedron Letters. 32(27). 3269–3272. 53 indexed citations
19.
Cox, J. P., Karl J. Jankowski, Ritu Kataky, et al.. (1989). Synthesis of a kinetically stable yttrium-90 labelled macrocycle–antibody conjugate. Journal of the Chemical Society Chemical Communications. 797–798. 65 indexed citations
20.
Beeley, Nigel R. A., et al.. (1981). Syntheses of PGF2α, and cloprostenol. Tetrahedron. 37. 411–420. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026